Prevalence of Apparent Treatment–Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis. (26th July 2022)
- Record Type:
- Journal Article
- Title:
- Prevalence of Apparent Treatment–Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis. (26th July 2022)
- Main Title:
- Prevalence of Apparent Treatment–Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis
- Authors:
- Vareta, Georgia
Georgianos, Panagiotis I
Vaios, Vasilios
Sgouropoulou, Vasiliki
Georgianou, Eleni I
Leivaditis, Konstantinos
Mavromatidis, Konstantinos
Dounousi, Evangelia
Papagianni, Aikaterini
Balaskas, Elias V
Zebekakis, Pantelis E
Liakopoulos, Vassilios - Abstract:
- Abstract: BACKGROUND: Apparent treatment–resistant hypertension (aTRH) is defined as failure to achieve adequate blood pressure (BP) control despite taking ≥3 antihypertensive medications from different categories or when taking ≥4 antihypertensives regardless of BP levels. METHODS: In this cross-sectional study, we estimated the prevalence of aTRH in 140 patients receiving long-term peritoneal dialysis (PD) in four centers of Northern Greece, using the "gold-standard" method of ambulatory BP monitoring for the assessment of BP control status. The presence of subclinical overhydration was evaluated with the method of bioimpedance spectroscopy (BIS). RESULTS: Incorporating the diagnostic threshold of 130/80 mmHg for 24-hour ambulatory BP, the prevalence of aTRH in the overall study population was 30%. Compared to patients without aTRH, those with aTRH tended to be older in age, had higher PD vintage, had higher dialysate-to-plasma creatinine ratio, had more commonly history of diabetes mellitus, and were more commonly current smokers. With respect to the volume status, the overhydration index in BIS was higher in those with versus without aTRH (2.0 ± 1.9 L vs. 1.1 ± 2.0 L, P < 0.05). The prevalence of volume overload, defined as an overhydration index in BIS > 2.5 L, was also higher in the subgroup of patients with aTRH (38.1% vs. 18.4, P = 0.01). CONCLUSION: The present study showed that among patients on PD, the prevalence of aTRH was 30%. However, 38% of PD patients withAbstract: BACKGROUND: Apparent treatment–resistant hypertension (aTRH) is defined as failure to achieve adequate blood pressure (BP) control despite taking ≥3 antihypertensive medications from different categories or when taking ≥4 antihypertensives regardless of BP levels. METHODS: In this cross-sectional study, we estimated the prevalence of aTRH in 140 patients receiving long-term peritoneal dialysis (PD) in four centers of Northern Greece, using the "gold-standard" method of ambulatory BP monitoring for the assessment of BP control status. The presence of subclinical overhydration was evaluated with the method of bioimpedance spectroscopy (BIS). RESULTS: Incorporating the diagnostic threshold of 130/80 mmHg for 24-hour ambulatory BP, the prevalence of aTRH in the overall study population was 30%. Compared to patients without aTRH, those with aTRH tended to be older in age, had higher PD vintage, had higher dialysate-to-plasma creatinine ratio, had more commonly history of diabetes mellitus, and were more commonly current smokers. With respect to the volume status, the overhydration index in BIS was higher in those with versus without aTRH (2.0 ± 1.9 L vs. 1.1 ± 2.0 L, P < 0.05). The prevalence of volume overload, defined as an overhydration index in BIS > 2.5 L, was also higher in the subgroup of patients with aTRH (38.1% vs. 18.4, P = 0.01). CONCLUSION: The present study showed that among patients on PD, the prevalence of aTRH was 30%. However, 38% of PD patients with aTRH had subclinical overhydration in BIS, suggesting that the achievement of adequate volume control may be a therapeutic opportunity to improve the management of hypertension in this high-risk patient population. The present study showed that among patients on PD, the prevalence of aTRH was 30%. However, 38% of PD patients with aTRH had subclinical overhydration in BIS, suggesting that the achievement of adequate volume control may be a therapeutic opportunity to improve the management of hypertension in this high-risk patient population. CLINICAL TRIALS REGISTRATION: Trial Number NCT03607747 Graphical Abstract: … (more)
- Is Part Of:
- American journal of hypertension. Volume 35:Number 11(2022)
- Journal:
- American journal of hypertension
- Issue:
- Volume 35:Number 11(2022)
- Issue Display:
- Volume 35, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 35
- Issue:
- 11
- Issue Sort Value:
- 2022-0035-0011-0000
- Page Start:
- 918
- Page End:
- 922
- Publication Date:
- 2022-07-26
- Subjects:
- ambulatory BP monitoring -- apparent treatment–resistant hypertension -- blood pressure -- hypertension -- peritoneal dialysis -- volume overload
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://ajh.oxfordjournals.org/ ↗
http://www.nature.com/ajh/index.html ↗
http://ukcatalogue.oup.com/ ↗
http://www.sciencedirect.com/science/journal/08957061 ↗ - DOI:
- 10.1093/ajh/hpac086 ↗
- Languages:
- English
- ISSNs:
- 0895-7061
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0826.400000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24330.xml